Brief exposure of mice to 60 Hz magnetic fields reduces the analgesic effects of the neuroactive steroid, 3α-hydroxy-4-pregnen-20-one

[1]  F. Prato,et al.  Evidence for the involvement of nitric oxide and nitric oxide synthase in the modulation of opioid-induced antinociception and the inhibitory effects of exposure to 60-Hz magnetic fields in the land snail , 1998, Brain Research.

[2]  R. Conley,et al.  Effects of antidepressant treatment on neuroactive steroids in major depression. , 1998, The American journal of psychiatry.

[3]  F. Hsu,et al.  GABAA receptor α4 subunit suppression prevents withdrawal properties of an endogenous steroid , 1998, Nature.

[4]  J. Kaprio,et al.  Magnetic fields of transmission lines and depression. , 1997, American journal of epidemiology.

[5]  S Ghione,et al.  Changes in pain perception and pain-related somatosensory evoked potentials in humans produced by exposure to oscillating magnetic fields , 1997, Brain Research.

[6]  J. Wiebe,et al.  Synthesis, metabolism and levels of the neuroactive steroid, 3α-hydroxy-4-pregnen-20-one (3αHP), in rat pituitaries , 1997, Brain Research.

[7]  C. Frye,et al.  Analgesic effects of the neurosteroid 3α-androstanediol , 1996, Brain Research.

[8]  Thorsten Trapp,et al.  Neurosteroids: Molecular mechanisms of action and psychopharmacological significance , 1996, The Journal of Steroid Biochemistry and Molecular Biology.

[9]  M. Kavaliers,et al.  Male preference for the odors of estrous female mice is enhanced by the neurosteroid 3α-hydroxy-4-pregnen-20-one (3αHP) , 1994, Brain Research.

[10]  D. Rubinow,et al.  CSF neuroactive steroids in affective disorders: Pregnenolone, progesterone, and DBI , 1994, Biological Psychiatry.

[11]  M. Kavaliers,et al.  Reduction of predator odor-induced anxiety in mice by the neurosteroid 3α-hydroxy-4-pregnen-20-one (3αHP) , 1994, Brain Research.

[12]  C. Frye,et al.  Progesterone metabolites, effective at the GABAA receptor complex, attenuate pain sensitivity in rats , 1994, Brain Research.

[13]  D A Savitz,et al.  Prevalence of depression among electrical workers. , 1994, American journal of industrial medicine.

[14]  M. Majewska,et al.  Neurosteroids: Endogenous bimodal modulators of the GABAA receptor mechanism of action and physiological significance , 1992, Progress in Neurobiology.

[15]  N. Krieger,et al.  Evidence that 3α-hydroxy-5α-pregnan-20-one is the metabolite responsible for anesthesia induced by 5α-pregnanedione in the mouse , 1992, Neuroscience Letters.

[16]  M. Kavaliers,et al.  Evidence for the involvement of protein kinase C in the modulation of morphine-induced ‘analgesia’ and the inhibitory effects of exposure to 60-Hz magnetic fields in the snail,Cepaea nemoralis , 1991, Brain Research.

[17]  D. Triggle,et al.  1,4-Dihydropyridine activators and antagonists: structural and functional distinctions. , 1989, Trends in pharmacological sciences.

[18]  M. Kavaliers,et al.  Analgesic effects of the putative FSH-suppressing gonadal steroid, 3α-hydroxy-4-pregnen-20-one: possible modes of action , 1988, Brain Research.

[19]  M. Kavaliers,et al.  Day-night rhythms of opioid and non-opioid stress-induced analgesia: differential inhibitory effects of exposure to magnetic fields , 1988, Pain.

[20]  Klaus-Peter Ossenkopp,et al.  Morphine-induced analgesia and exposure to low-intensity 60-Hz magnetic fields: inhibition of nocturnal analgesia in mice is a function of magnetic field intensity , 1987, Brain Research.

[21]  M. Kavaliers,et al.  Analgesic effects of the progesterone metabolite, 3α-hydroxy-5α-pregnan-20-one, and possible modes of action in mice , 1987, Brain Research.

[22]  S. Paul,et al.  Anxiolytic activity of an endogenous adrenal steroid , 1986, Brain Research.

[23]  J. Wiebe,et al.  Synthesis of the allylic gonadal steroids, 3α-hydroxy-4-pregnen-20-one and 3α-hydroxy-4-androsten-17-one, and of 3α-hydroxy-5α-pregnan-20-one , 1985, Steroids.

[24]  T. Haley,et al.  Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. , 1957, British journal of pharmacology and chemotherapy.

[25]  W. R. Adey,et al.  Extremely-low-frequency magnetic fields disrupt rhythmic slow activity in rat hippocampal slices. , 1996, Bioelectromagnetics.

[26]  J. Wiebe,et al.  Suppression of follicle-stimulating hormone by the gonadal- and neurosteroid 3 alpha-hydroxy-4-pregnen-20-one involves actions at the level of the gonadotrope membrane/calcium channel. , 1994, Endocrinology.

[27]  J. Wiebe,et al.  Suppression in gonadotropes of gonadotropin-releasing hormone-stimulated follicle-stimulating hormone release by the gonadal- and neurosteroid 3 alpha-hydroxy-4-pregnen-20-one involves cytosolic calcium. , 1994, Endocrinology.

[28]  R. Tsien,et al.  Molecular diversity of voltage-dependent Ca2+ channels. , 1991, Trends in pharmacological sciences.